☰

Thomas Cook, Ph.D. - Publications

Affiliations: 
Northwestern University, Evanston, IL 
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Johnston P, Duckers E, Raval A, Cook T, Traverse J, Abraham W, Altman P, Pepine C. TCT-747 The CardiAMP Heart Failure Study: First Results from Unblinded Roll-In Phase Journal of the American College of Cardiology. 72. DOI: 10.1016/J.Jacc.2018.08.1971  0.309
2016 Hallberg K, Cook TD, Steiner PM, Clark MH. Pretest Measures of the Study Outcome and the Elimination of Selection Bias: Evidence from Three Within Study Comparisons. Prevention Science : the Official Journal of the Society For Prevention Research. PMID 27848116 DOI: 10.1007/S11121-016-0732-6  0.447
2013 Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. European Heart Journal. 34: 835-43. PMID 23293303 DOI: 10.1093/Eurheartj/Ehs444  0.333
2011 Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Konstam MA, et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. European Heart Journal. 32: 2563-72. PMID 21785107 DOI: 10.1093/Eurheartj/Ehr238  0.312
2010 Wang NC, Piccini JP, Konstam MA, Maggioni AP, Traver B, Swedberg K, Udelson JE, Zannad F, Cook T, O'Connor CM, Miller AB, Grinfeld L, Gheorghiade M. Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction. American Journal of Therapeutics. 17: e78-87. PMID 20634650 DOI: 10.1097/Mjt.0B013E3181E70A65  0.315
2010 O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Piña I, Roth S, Sackner-Bernstein JD, ... ... Cook T, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. American Heart Journal. 159: 841-849.e1. PMID 20435194 DOI: 10.1016/J.Ahj.2010.02.023  0.359
2010 Pang PS, Zannad F, Konstam M, Burnett J, Udelson J, Swedberg K, Grinfeld L, Maggioni AP, Cook T, Gheorghiade M. 40: Changes In the Neurohormonal Profile of Patients Hospitalized for Acute Heart Failure Syndromes During the Early Post-Discharge Period According to Early, Late, or No Heart Failure Re-Hospitalization or Mortality Events: Analysis From the EVEREST Trials Annals of Emergency Medicine. 56. DOI: 10.1016/J.Annemergmed.2010.06.070  0.344
2008 Blair JEA, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program Journal of the American College of Cardiology. 52: 1640-1648. PMID 18992654 DOI: 10.1016/J.Jacc.2008.07.056  0.379
2008 Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Jama. 299: 2656-66. PMID 18544725 DOI: 10.1001/Jama.299.22.2656  0.363
2008 Wang NC, Maggioni AP, Konstam MA, Krasa HB, Zannad F, Cook T, Traver B, Gheorghiade M. 246 Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program European Journal of Heart Failure Supplements. 7: 58-58. DOI: 10.1016/S1567-4215(08)60158-7  0.327
2008 Blair J, Zannad F, Konstam M, Cook T, Burnett J, Grinfield L, Maggioni A, Swedberg K, Udelson J, Gheorghiade M. 35 Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program European Journal of Heart Failure Supplements. 7: 2-2. DOI: 10.1016/S1567-4215(08)60007-7  0.323
2007 Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. Jama. 297: 1332-43. PMID 17384438 DOI: 10.1001/Jama.297.12.1332  0.356
2007 Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. Jama. 297: 1319-31. PMID 17384437 DOI: 10.1001/Jama.297.12.1319  0.376
2007 Wang NC, Zannad F, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. The QRS Interval Predicts Mortality and Re-Hospitalization in Patients Hospitalized with Worsening Heart Failure and Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.544  0.322
2007 Wang NC, Konstam MA, Gheorghiade M, Bechhofer R, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP, Zannad F. Regional Comparison of Baseline Therapy in Patients Hospitalized for Acute Heart Failure with Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.515  0.333
2007 Zannad F, Wang NC, Konstam MA, Bechhofer R, Gheorghiade M, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Ouyang J, Zimmer C, Orlandi C, Maggioni AP. Regional Differences in Baseline Characteristics and Outcomes in Patients Hospitalized with Worsening Heart Failure and Systolic Dysfunction Journal of Cardiac Failure. 13. DOI: 10.1016/J.Cardfail.2007.06.323  0.343
2001 Lewis RJ, Berry DA, Cryer H, Fost N, Krome R, Washington GR, Houghton J, Blue JW, Bechhofer R, Cook T, Fisher M. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: The diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial Annals of Emergency Medicine. 38: 397-404. PMID 11574796 DOI: 10.1067/Mem.2001.118223  0.315
Show low-probability matches.